Recombinant Human IL-36γ Protein，His

IL-36γ, a member of the interleukin-36 (IL-36) cytokine family, has garnered significant attention in recent immunological research due to its pro-inflammatory properties and implications in various autoimmune and inflammatory diseases, including psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Discovered as a vital player in the innate immune response, IL-36γ is predominantly produced by epithelial cells and plays a crucial role in the activation of immune cells, thereby regulating both the innate and adaptive immune responses. Its interaction with the IL-36 receptor complex leads to the activation of signaling pathways that drive the expression of other pro-inflammatory cytokines, contributing to pathogenic processes in chronic inflammatory conditions. Consequently, the recombinant production of IL-36γ protein has become a pivotal focus for scientists aiming to elucidate its biological functions and therapeutic potential. Research efforts leverage recombinant DNA technology to produce functional IL-36γ, facilitating in vitro and in vivo studies that assess its role in immune modulation and its potential as a therapeutic target. Understanding the mechanistic pathways associated with IL-36γ may pave the way for novel treatment strategies for diseases characterized by dysregulated immune responses. Moreover, the development of IL-36γ antagonists or neutralizing antibodies could offer promising avenues for mitigating inflammation and restoring immune homeostasis in affected patients, thus underscoring the significance of IL-36γ research in contemporary immunology.